100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4,6 TrustPilot
logo-home
Examen

Comprehensive Gastrointestinal Pharmacology Test Bank: Practice Questions 1–150 Answers And Rationale 2025/2026

Puntuación
-
Vendido
-
Páginas
43
Grado
A+
Subido en
10-12-2025
Escrito en
2025/2026

Comprehensive Gastrointestinal Pharmacology Test Bank: Practice Questions 1–150 Answers And Rationale 2025/2026

Institución
Comprehensive Gastrointestinal Pharmacology
Grado
Comprehensive Gastrointestinal Pharmacology











Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Escuela, estudio y materia

Institución
Comprehensive Gastrointestinal Pharmacology
Grado
Comprehensive Gastrointestinal Pharmacology

Información del documento

Subido en
10 de diciembre de 2025
Número de páginas
43
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

Comprehensive Gastrointestinal
Pharmacology Test Bank: Practice
Questions 1–150 Answers And
Rationale
2025/2026
1. Which of the following drugs is a proton pump inhibitor used to
treat GERD?
a) Ranitidine
b) Famotidine
c) Omeprazole
d) Sucralfate
Rationale: Omeprazole is a proton pump inhibitor (PPI) that
irreversibly inhibits the H+/K+ ATPase in gastric parietal cells,
reducing acid secretion.
2. Which drug is classified as an H2 receptor antagonist?
a) Ranitidine
b) Omeprazole
c) Misoprostol
d) Aluminum hydroxide
Rationale: Ranitidine blocks H2 receptors on gastric parietal cells,
reducing acid production.
3. A patient with peptic ulcer disease is prescribed a cytoprotective
agent. Which drug fits this category?
a) Esomeprazole
b) Sucralfate

, c) Metoclopramide
d) Loperamide
Rationale: Sucralfate forms a protective barrier over ulcers, shielding
them from acid and pepsin.
4. Which of the following is a prokinetic agent that enhances
gastrointestinal motility?
a) Omeprazole
b) Metoclopramide
c) Lansoprazole
d) Ranitidine
Rationale: Metoclopramide increases gastric emptying and
gastrointestinal motility by antagonizing dopamine D2 receptors.
5. A patient has diarrhea caused by traveler's diarrhea. Which
antidiarrheal agent is appropriate?
a) Bismuth subsalicylate
b) Loperamide
c) Misoprostol
d) Sucralfate
Rationale: Loperamide slows intestinal motility and increases
absorption, reducing diarrhea.
6. Which of the following medications is used to prevent NSAID-
induced gastric ulcers?
a) Omeprazole
b) Ranitidine
c) Misoprostol
d) Aluminum hydroxide
Rationale: Misoprostol is a prostaglandin E1 analog that increases
mucus and bicarbonate secretion, protecting the stomach lining.

, 7. Which drug neutralizes stomach acid by chemically reacting with
it?
a) Omeprazole
b) Ranitidine
c) Magnesium hydroxide
d) Metoclopramide
Rationale: Magnesium hydroxide is an antacid that directly
neutralizes gastric acid to increase pH.
8. A patient with gastroesophageal reflux disease (GERD) is advised
to take a drug that irreversibly inhibits acid secretion. Which is
recommended?
a) Ranitidine
b) Pantoprazole
c) Sucralfate
d) Aluminum hydroxide
Rationale: Pantoprazole is a PPI that irreversibly inhibits H+/K+
ATPase, providing potent acid suppression.
9. Which of the following is a bulk-forming laxative?
a) Bisacodyl
b) Psyllium
c) Magnesium citrate
d) Docusate sodium
Rationale: Psyllium absorbs water and forms a gel, increasing stool
bulk and promoting bowel movements.
10. Which laxative works by stimulating intestinal smooth
muscle?
a) Psyllium
b) Docusate sodium

, c) Bisacodyl
d) Lactulose
Rationale: Bisacodyl stimulates enteric nerves, enhancing peristalsis.
11. Which osmotic laxative is safe for long-term use in hepatic
encephalopathy?
a) Magnesium hydroxide
b) Lactulose
c) Bisacodyl
d) Senna
Rationale: Lactulose reduces ammonia absorption in the gut and is
used in hepatic encephalopathy management.
12. Which drug can be used as an antiemetic by blocking
serotonin 5-HT3 receptors?
a) Metoclopramide
b) Prochlorperazine
c) Ondansetron
d) Dimenhydrinate
Rationale: Ondansetron selectively blocks 5-HT3 receptors in the GI
tract and chemoreceptor trigger zone, preventing nausea and
vomiting.
13. Which antiemetic is a dopamine D2 receptor antagonist?
a) Ondansetron
b) Dimenhydrinate
c) Prochlorperazine
d) Meclizine
Rationale: Prochlorperazine blocks dopamine receptors in the
chemoreceptor trigger zone to prevent nausea.
$21.99
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor
Seller avatar
frendinanyawira

Conoce al vendedor

Seller avatar
frendinanyawira Teachme2-tutor
Ver perfil
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
1
Miembro desde
2 meses
Número de seguidores
1
Documentos
659
Última venta
2 meses hace

0.0

0 reseñas

5
0
4
0
3
0
2
0
1
0

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes